{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:30:11Z","timestamp":1788964211036,"version":"build-2803163510"},"reference-count":15,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2022,10]]},"abstract":"Abstract<\/jats:title>\n \n Aim<\/jats:title>\n To evaluate the impact of the stay\u2010at\u2010home policy on different glucose metrics for time in range (%TIR 3.9\u201010\u2009mmol\/L), time below range (%TBR <\u20093.9\u2009mmol\/L) and time above range (%TAR >\u200910\u2009mmol\/L) for UK adult FreeStyle Libre (FSL) users within four defined age groups and on observed changes during the coronavirus disease 2019 (COVID\u201019) pandemic.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Data were extracted from 8914 LibreView de\u2010identified user accounts for adult users aged 18\u2009years or older with 5\u2009or more days of sensor readings in each month from January to June 2020. Age\u2010group categories were based on self\u2010reported age on LibreView accounts (18\u201025, 26\u201049, 50\u201064 and \u226565\u2009years).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In January, prior to the COVID\u201019 pandemic, the 65\u2009years or older age group had the highest %TIR (57.9%), while the 18\u201025\u2009years age group had the lowest (51.2%) (\n P<\/jats:italic>\n \u00a0<\u2009.001). Within each age group, TIR increased during the analysed months, by 1.7% (26\u201049\u2009years) to 3.1% (\u226565\u2009years) (\n P<\/jats:italic>\n \u00a0<\u2009.001 in all cases). %TBR was significantly reduced only in the 26\u201049\u2009years age group, whereas %TAR was reduced by 1.5% (26\u201049\u2009years) to 3.0% (\u226565\u2009years) (\n P<\/jats:italic>\n \u00a0<\u2009.001 in both cases). The proportion of adults achieving both of the more than 70% TIR and\u2009less than 4% TBR targets increased from 11.7% to 15.9% for those aged 65\u2009years or older (\n P<\/jats:italic>\n \u00a0<\u2009.001) and from 6.0% to 9.1% for those aged 18\u201025\u2009years (\n P<\/jats:italic>\n \u00a0<\u2009.05). Mean daily glucose\u2010sensor scan rates were at least 12 per day and remained stable across the analysis period.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Our data show the baseline glucose metrics for FSL users in the UK across different age groups under usual care. During lockdown in the UK, the proportion of adults achieving TIR consensus targets increased among FSL users.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/dom.14782","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T04:49:02Z","timestamp":1653972542000},"page":"1976-1982","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glycaemic measures for 8914 adult\n FreeStyle<\/scp>\n Libre users during routine care, segmented by age group and observed changes during the\n COVID<\/scp>\n \u201019 pandemic"],"prefix":"10.1111","volume":"24","author":[{"given":"Pratik","family":"Choudhary","sequence":"first","affiliation":[{"name":"Diabetes Research Centre University of Leicester Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalvin","family":"Kao","sequence":"additional","affiliation":[{"name":"Reseach and development Abbott Laboratories Alameda California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Reseach and development Abbott Laboratories Alameda California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brandner","sequence":"additional","affiliation":[{"name":"Reseach and development Abbott Laboratories Alameda California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Rayman","sequence":"additional","affiliation":[{"name":"Ipswich Diabetes Centre East Suffolk and North East Essex Foundation Trust Ipswich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma G.","family":"Wilmot","sequence":"additional","affiliation":[{"name":"Diabetes Department, Royal Derby Hospital University Hospitals of Derby and Burton NHS Foundation Trust Derby UK"},{"name":"Faculty of Medicine and Health Sciences University of Nottingham Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,17]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820924469"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0660"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30272-2"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30271-0"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14374"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01614-5"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00829-7"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108348"},{"key":"e_1_2_9_11_1","unstructured":"NHS England.Flash Glucose Monitoring: National Arrangements for Funding of Relevant Diabetes Patients.2019.https:\/\/www.england.nhs.uk\/publication\/flash-glucose-monitoring-national-arrangements-for-funding-of-relevant-diabetes-patients\/. Accessed February 23 2022."},{"key":"e_1_2_9_12_1","unstructured":"Health Improvement Scotland\/SHTG Advice on Health Technologies.What is the clinical and cost effectiveness of FreeStyle Libre flash glucose monitoring for patients with diabetes mellitus treated with intensive insulin therapy. Evidence Note Number 81.2018.http:\/\/www.healthcareimprovementscotland.org\/our_work\/technologies_and_medicines\/topics_assessed\/shtg_009-18.aspx. Accessed December 1 2021."},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0738"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.12.015"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0078"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.14782","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.14782","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.14782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:22:42Z","timestamp":1761862962000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.14782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,17]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1111\/dom.14782"],"URL":"https:\/\/doi.org\/10.1111\/dom.14782","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.14782\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14782\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14782\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14782\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14782\/v1\/review4","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14782\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14782\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14782\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14782\/v2\/review1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,17]]},"assertion":[{"value":"2022-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}